These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34452057)

  • 21. A live experimental vaccine against Burkholderia pseudomallei elicits CD4+ T cell-mediated immunity, priming T cells specific for 2 type III secretion system proteins.
    Haque A; Chu K; Easton A; Stevens MP; Galyov EE; Atkins T; Titball R; Bancroft GJ
    J Infect Dis; 2006 Nov; 194(9):1241-8. PubMed ID: 17041850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the protective effects of killed Burkholderia pseudomallei and CpG oligodeoxynucleotide against live challenge.
    Puangpetch A; Anderson R; Huang YY; Saengsot R; Sermswan RW; Wongratanacheewin S
    Vaccine; 2014 Oct; 32(45):5983-8. PubMed ID: 25223269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dendritic Cell-Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma.
    Dey M; Chang AL; Miska J; Wainwright DA; Ahmed AU; Balyasnikova IV; Pytel P; Han Y; Tobias A; Zhang L; Qiao J; Lesniak MS
    J Immunol; 2015 Jul; 195(1):367-76. PubMed ID: 26026061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection against heterologous Burkholderia pseudomallei strains by dendritic cell immunization.
    Elvin SJ; Healey GD; Westwood A; Knight SC; Eyles JE; Williamson ED
    Infect Immun; 2006 Mar; 74(3):1706-11. PubMed ID: 16495542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
    Zitvogel L; Mayordomo JI; Tjandrawan T; DeLeo AB; Clarke MR; Lotze MT; Storkus WJ
    J Exp Med; 1996 Jan; 183(1):87-97. PubMed ID: 8551248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced efficacy of therapeutic cancer vaccines produced by co-treatment with Mycobacterium tuberculosis heparin-binding hemagglutinin, a novel TLR4 agonist.
    Jung ID; Jeong SK; Lee CM; Noh KT; Heo DR; Shin YK; Yun CH; Koh WJ; Akira S; Whang J; Kim HJ; Park WS; Shin SJ; Park YM
    Cancer Res; 2011 Apr; 71(8):2858-70. PubMed ID: 21368092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of human monocyte-derived dendritic cells by Burkholderia pseudomallei does not require binding to the C-type lectin DC-SIGN.
    Charoensap J; Engering A; Utaisincharoen P; van Kooyk Y; Sirisinha S
    Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S76-81. PubMed ID: 19121694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cells.
    Sköld AE; Mathan TSM; van Beek JJP; Flórez-Grau G; van den Beukel MD; Sittig SP; Wimmers F; Bakdash G; Schreibelt G; de Vries IJM
    Cancer Immunol Immunother; 2018 Sep; 67(9):1425-1436. PubMed ID: 30019146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of protective immunity in a murine model of melioidosis is influenced by the source of Burkholderia pseudomallei antigens.
    Barnes JL; Ketheesan N
    Immunol Cell Biol; 2007 Oct; 85(7):551-7. PubMed ID: 17563759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Allogeneic dendritic cell vaccine pulsed with heat shocked tumor cell lysate can enhance antitumor immunity].
    You J; Wang CL; Hao XS
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2785-90. PubMed ID: 18167273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Migration of dendritic cells facilitates systemic dissemination of Burkholderia pseudomallei.
    Williams NL; Morris JL; Rush CM; Ketheesan N
    Infect Immun; 2014 Oct; 82(10):4233-40. PubMed ID: 25069976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CpG-C immunostimulatory oligodeoxyribonucleotide activation of plasmacytoid dendritic cells in rhesus macaques to augment the activation of IFN-gamma-secreting simian immunodeficiency virus-specific T cells.
    Teleshova N; Kenney J; Jones J; Marshall J; Van Nest G; Dufour J; Bohm R; Lifson JD; Gettie A; Pope M
    J Immunol; 2004 Aug; 173(3):1647-57. PubMed ID: 15265893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity.
    Yang S; Vervaert CE; Burch J; Grichnik J; Seigler HF; Darrow TL
    Int J Cancer; 1999 Nov; 83(4):532-40. PubMed ID: 10508491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human blood myeloid and plasmacytoid dendritic cells cross activate each other and synergize in inducing NK cell cytotoxicity.
    van Beek JJ; Gorris MA; Sköld AE; Hatipoglu I; Van Acker HH; Smits EL; de Vries IJ; Bakdash G
    Oncoimmunology; 2016; 5(10):e1227902. PubMed ID: 27853652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urban particulate matter stimulation of human dendritic cells enhances priming of naive CD8 T lymphocytes.
    Pfeffer PE; Ho TR; Mann EH; Kelly FJ; Sehlstedt M; Pourazar J; Dove RE; Sandstrom T; Mudway IS; Hawrylowicz CM
    Immunology; 2018 Apr; 153(4):502-512. PubMed ID: 29044495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection.
    Nieves W; Asakrah S; Qazi O; Brown KA; Kurtz J; Aucoin DP; McLachlan JB; Roy CJ; Morici LA
    Vaccine; 2011 Oct; 29(46):8381-9. PubMed ID: 21871517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumour necrosis factor-alpha (TNF-alpha) transgene-expressing dendritic cells (DCs) undergo augmented cellular maturation and induce more robust T-cell activation and anti-tumour immunity than DCs generated in recombinant TNF-alpha.
    Zhang W; Chen Z; Li F; Kamencic H; Juurlink B; Gordon JR; Xiang J
    Immunology; 2003 Feb; 108(2):177-88. PubMed ID: 12562326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crosstalk between human DC subsets promotes antibacterial activity and CD8+ T-cell stimulation in response to bacille Calmette-Guérin.
    Lozza L; Farinacci M; Faé K; Bechtle M; Stäber M; Dorhoi A; Bauer M; Ganoza C; Weber S; Kaufmann SH
    Eur J Immunol; 2014 Jan; 44(1):80-92. PubMed ID: 24114554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myeloid and plasmacytoid dendritic cell combined vaccines loaded with heat-treated tumor cell lysates enhance antitumor activity in murine lung cancer.
    Chen H; Tan J; Li X; Li H; Wu W; Wu Y; Zhang J; Gu L
    Oncol Lett; 2021 Feb; 21(2):90. PubMed ID: 33376523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation.
    Boonstra A; Asselin-Paturel C; Gilliet M; Crain C; Trinchieri G; Liu YJ; O'Garra A
    J Exp Med; 2003 Jan; 197(1):101-9. PubMed ID: 12515817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.